The application of high intense focused ultrasound (HIFU) is currently the subject of many experimental and clinical trials. The combination of HIFU with MRI guidance known as MR-guided focused ultrasound (MRgFUS) appears to be particularly promising to ablate tissues located deep in the brain. The method can be the beginning of interventional neurology and an important alternative to neurosurgery. Studies conducted to date show the effectiveness of the method both in chronic diseases and in emergency cases. The safety and effectiveness of this method have been observed in parkinsonian and essential tremor as well as in neuropathic pain. The procedure does not require anaesthesia. Ionizing radiation is not used and there is no risk of cumulative dose. Such advantages may result in low complication rates and medical justification for further development of MRgFUS.
MoserDZadicarioESchiffG. Measurement of targeting accuracy in focused ultrasound functional neurosurgery. Neurosurg Focus. 2012; 32 (1): E2. doi: 10.3171/2011.10.FOCUS11246.
2.
HariharanPMyersMRBanerjeeRK. HIFU procedures at moderate intensities—effect of large blood vessel. Phys. Med. Biol. 2007; 52: 3493–3513. doi: 10.1088/0031-9155/52/12/011.
3.
SaparetoSADeweyWC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984; 10 (6): 787–800. doi: 10.1016/0360-3016(84)90379-1.
4.
CorbettRJLaptookARTollefsbolG. Validation of a noninvasive method to measure brain temperature in vivo using 1H NMR spectroscopy. J Neurochem. 1995; 64 (3): 1224–1230. doi: 10.1046/j.1471-4159.1995.64031224.x.
5.
CorbettRLaptookARWeatherallP. Noninvasive measurements of human brain temperature using volume-localized proton magnetic resonance spectroscopy. J Cereb Blood Flow Metab. 1997; 17 (4): 363–369. doi: 10.1097/00004647-199704000-00001.
6.
WoodEWLoomisAL. The physical and biological effects of high-frequency sound-waves of great intensity. Philos Mag.1927; Series 7 (4): 417–436.
7.
LynnJZwemerRChickA. A new method for the generation and use of focused ultrasound in experimental biology. J. Gen. Physiol. 1942; 26 (6): 179–193. doi: 10.1085/jgp.26.2.179.
8.
FryWBarnardJFryF. Ultrasonic lesions in the mammalian central nervous system. Science. 1942; 122: 517–518. doi: 10.1126/science.122.3168.517.
9.
FryWJMosbergWHBarnardJW. Production of focal destructive lesions in the central nervous system with ultrasound. J. Neurosurg. 1954; 11 (5): 471–478. doi: 10.3171/jns.1954.11.5.0471.
10.
MeyersRFryWJFryFJ. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg. 1959; 16 (1): 32–54. doi: 10.3171/jns.1959.16.1.0032.
11.
VykhodtsevaNMcDannoldNMartinH. Apoptosis in ultrasound-produced threshold lesions in the rabbit brain. Ultrasound Med Biol. 2001; 27 (1): 111–117. doi: 10.1016/S0301-5629(00)00275-1.
12.
DeuschlGBainPBrinM. Consensus statement of the Movement Disorder Society on tremor. Ad Hoc Scientific Committee. Mov Disord. 1998; 13 (suppl 3): 2–23. doi: 10.1002/mds.870131303.
13.
ZesiewiczTAElbleRJLouisED. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology. 2011; 77 (19): 1752–1755. doi: 10.1212/WNL.0b013e318236f0fd.
14.
EliasWJHussDVossT. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med.2013; 369 (7): 640–648. doi: 10.1056/NEJMoa130 0962.
15.
LipsmanNSchwartzMLHuangY. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol. 2013; 12 (5): 462–468. doi: 10.1016/S1474-4422(13)70048-6.
16.
HorstinkMTolosaEBonuccelliU. European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol. 2006; 13 (11): 1170–1185. doi: 10.1111/j.1468-1331.2006.01547.x.
17.
HorstinkMTolosaEBonuccelliU. European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur J Neurol. 2006; 13 (11): 1186–1202. doi: 10.1111/j.1468-1331.2006.01548.x.
18.
FerreiraJJKatzenschlagerRBloemBR. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol. 2013; 20 (1): 5–15. doi: 10.1111/j.1468-1331.2012.03866.x.
19.
BerardelliAWenningGKAntoniniA. EFNS/MDS-ES/ENS corrected recommendations for the diagnosis of Parkinson's disease. Eur J Neurol. 2013; 20 (1): 16–34. doi: 10.1111/ene.12022.
20.
JeanmonodDMoserDMagaraD. Study on incisionless transcranial MR-guided focused ultrasound treatment of Parkinson's disease; safety accuracy and initial clinical outcomes. Current and future applications of focused ultrasound; 2012 Oct 14–17, Washington.
21.
Consensus guidelines: treatment planning and options. Mayo Clin. Proc. 2006; 81 (suppl. 4): 12–25. doi: 10.1016/S0025-6196(11)61475-4.
22.
AttalNGruccuGHaanpaaM. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur. J. Neurol. 2006; 13 (11): 1153–1169. doi: 10.1111/j.1468-1331.2006.01511.x.
23.
DworkinRHO'ConnorABAudetteJ. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010; 85 (Suppl): S3–14. doi: 10.4065/mcp.2009.0649.
24.
JeanmonodDMagninMMorelA. Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms. Brain. 1996; 119 (Pt 2): 363–375. doi: 10.1093/brain/119.2.363.
25.
SarntheinJSternJAufenbergC. Increased EEG power and slowed dominant frequency in patients with neurogenic pain. Brain. 2006; 129 (Pt 1): 55–64. doi: 10.1093/brain/awh631.
26.
JeanmonodDMagninMMorelA. Surgical control of the human thalamocortical dysrhythmia: I. Central lateral thalamotomy in neurogenic pain. Thalamus & Related Systems. 2001; 1: 245–254. doi: 10.1016/S1472-9288(01)00026-7.
27.
JeanmonodDWernerBMorelA. Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus. 2012; 32 (1): 1–11. doi: 10.3171/2011.10.FOCUS11248.
28.
HynynenKMcDannoldNSheikovNA. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005; 24 (1): 12–20. doi: 10.1016/j.neuroimage.2004.06.046.
29.
McDannoldNArvanitisCDVykhodtsevaN. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res.2012; 72 (14): 3652–3663. doi: 10.1158/0008-5472.CAN-12-0128.
30.
AlkinsRBurgessAGangulyM. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res.2013; 73 (6): 1892–1899. doi: 10.1158/0008-5472.CAN-12-2609.
31.
MonteithSJHarnofSMedelR. Minimally invasive treatment of intracerebral hemorrhage with magnetic resonance-guided focused ultrasound. J Neurosurg. 2013; 118 (5): 1035–1045. doi: 10.3171/2012.12.JNS 121095.
32.
McDannoldNClementGTBlackP. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery. 2010; 66 (2): 323–332. doi: 10.1227/01.NEU.0000360379.95800.2F.
33.
BoisonD. The sound of noninvasive seizure control. Epilepsy Curr. 2011; 11 (6): 196–197. doi: 10.5698/1535-7511-11.6.196.
34.
Bor-Seng-ShuENogueiraR de CFigueiredoEG. Sonothrombolysis for acute ischemic stroke: a systematic review of randomized controlled trials. Neurosurg Focus. 2012; 32 (1): E5. doi: 10.3171/2011.10.FOCUS11251.
35.
HölscherTFisherDJRamanR. Noninvasive transcranial clot lysis using high intensity focused ultrasound. J Neurol Neurophysiol. 2011; S1. doi: 10.4172/2155-9562.S1-002.
36.
WrightCHynynenKGoertzD. In vitro and in vivo high-intensity focused ultrasound thrombolysis. Invest Radiol. 2012; 47 (4): 217–225. doi: 10.1097/RLI.0b013e31823cc75c.
37.
BurgessAHuangYWaspeAC. High-intensity focused ultrasound (HIFU) for dissolution of clots in a rabbit model of embolic stroke. PLoS One.2012; 7 (8): e42311. doi: 10.1371/journal.pone.0042311.
